MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could decide who gets extra immunotherapy after bladder cancer surgery
Disease control Recruiting nowThis study looks at whether a simple blood test can find leftover cancer DNA after surgery for bladder or urinary tract cancer. Patients with detectable DNA may need extra treatment with immunotherapy drugs (nivolumab with or without relatlimab) to lower the risk of cancer coming…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:11 UTC
-
New drug cocktail may let bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests whether a combination of two drugs (enfortumab vedotin and pembrolizumab) can shrink muscle-invasive bladder cancer enough to avoid bladder removal surgery. About 47 adults with stage T2-3 bladder cancer will receive the drugs for several months. If the cancer di…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
Can fewer radiation blasts beat bladder cancer just as well?
Disease control Recruiting nowThis study compares two ways of giving radiation therapy for muscle-invasive bladder cancer. One group gets the usual number of radiation sessions (hypofractionation) and the other gets even fewer, higher-dose sessions (ultra-hypofractionation), both combined with standard chemot…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Bladder-Sparing combo shows promise in avoiding surgery
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug pembrolizumab along with radiation therapy after chemotherapy can help people with muscle invasive bladder cancer keep their bladder instead of having it surgically removed. About 111 participants will receive this combinatio…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New DNA test may spot hidden bladder cancer before surgery
Diagnosis Recruiting nowThis study is testing whether a combination of a blood test and a urine test can detect aggressive muscle-invasive bladder cancer that standard scopes might miss. About 92 people scheduled for bladder removal surgery will provide samples before their operation. If the tests prove…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated May 14, 2026 12:06 UTC